Search Results - "Brunetta, P."

Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER) by Merrill, JT, Buyon, JP, Furie, RA, Latinis, KM, Gordon, C, Hsieh, H-J, Brunetta, P

“…The EXPLORER study was designed to assess the response to rituximab versus placebo in patients with moderate to severe extrarenal systemic lupus erythematosus…”
Get full text

International consensus for a definition of disease flare in lupus by Ruperto, N, Hanrahan, LM, Alarcón, GS, Belmont, HM, Brey, RL, Brunetta, P, Buyon, JP, Costner, MI, Cronin, ME, Dooley, MA, Filocamo, G, Fiorentino, D, Fortin, PR, Franks, AG, Gilkeson, G, Ginzler, E, Gordon, C, Grossman, J, Hahn, B, Isenberg, DA, Kalunian, KC, Petri, M, Sammaritano, L, Sánchez-Guerrero, J, Sontheimer, RD, Strand, V, Urowitz, M, von Feldt, JM, Werth, VP, Merrill, JT

“…The Lupus Foundation of America (LFA) convened an international working group to obtain a consensus definition of disease flare in lupus. With help from the…”
Get full text

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis by Miloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St.Clair, E. W., Tchao, N. K., Viviano, L., Ding, L., Sejismundo, L. P., Mieras, K., Iklé, D., Jepson, B., Mueller, M., Brunetta, P., Allen, N. B., Fervenza, F. C., Geetha, D., Keogh, K., Kissin, E. Y., Monach, P. A., Peikert, T., Stegeman, C., Ytterberg, S. R., Stone, J. H.

“…Objective To evaluate the reasons that complete remission is not achieved or maintained with original treatment in some patients with antineutrophil…”
Get full text

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis by Miloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St.Clair, E. W., Tchao, N. K., Viviano, L., Ding, L., Iklé, D., Villarreal, M., Jepson, B., Brunetta, P., Allen, N. B., Fervenza, F. C., Geetha, D., Keogh, K., Kissin, E. Y., Monach, P. A., Peikert, T., Stegeman, C., Ytterberg, S. R., Stone, J. H.

“…Objective Disease relapses are frequent in antineutrophil cytoplasmic antibody–associated vasculitis (AAV). This study was undertaken to evaluate outcomes in…”
Get full text

Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated With Glucocorticoids by Miloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St.Clair, E. W., Tchao, N. K., Ding, L., Iklé, D., Villareal, M., Lim, N., Brunetta, P., Fervenza, F. C., Monach, P. A., Stone, J. H.

“…Objective Nonsevere relapses are more common than severe relapses in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV), but their clinical…”
Get full text

Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following Rituximab treatment in systemic lupus erythematosus by Tew, GW, Rabbee, N., Wolslegel, K., Hsieh, H-J., Monroe, JG, Behrens, TW, Brunetta, PG, Keir, ME

“…B cells are thought to play a major role in the pathogenesis of systemic lupus erythematosus (SLE). Rituximab (RTX), a chimeric anti-CD20 mAb, effectively…”
Get full text

Racial Disparity in Rates of Surgery for Lung Cancer by King, Talmadge E, Brunetta, Paul

“…Lung cancer is the leading cause of death from cancer in the United States, accounting for more deaths per year than cancers of the breast, colon, prostate,…”
Get full text

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study by Rovin, Brad H., Furie, Richard, Latinis, Kevin, Looney, R. John, Fervenza, Fernando C., Sanchez-Guerrero, Jorge, Maciuca, Romeo, Zhang, David, Garg, Jay P., Brunetta, Paul, Appel, Gerald

“…Objective To evaluate the efficacy and safety of rituximab in a randomized, double‐blind, placebo‐controlled phase III trial in patients with lupus nephritis…”
Get full text

Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis by Miloslavsky, Eli M, Naden, Ray P, Bijlsma, Johannes W J, Brogan, Paul A, Brown, E Sherwood, Brunetta, Paul, Buttgereit, Frank, Choi, Hyon K, DiCaire, Jean-Francois, Gelfand, Jeffrey M, Heaney, Liam G, Lightstone, Liz, Lu, Na, Murrell, Dedee F, Petri, Michelle, Rosenbaum, James T, Saag, Kenneth S, Urowitz, Murray B, Winthrop, Kevin L, Stone, John H

“…To develop a Glucocorticoid Toxicity Index (GTI) to assess glucocorticoid (GC)-related morbidity and GC-sparing ability of other therapies. Nineteen experts on…”
Get more information

Subgroups of luteinizing hormone-releasing hormone perikarya defined by computer analyses in the basal forebrain of intact female rats by Hiatt, E S, Brunetta, P G, Seiler, G R, Barney, S A, Selles, W D, Wooledge, K H, King, J C

“…The hypothesis that the basal forebrain population of LHRH perikarya is composed of heterogeneous subgroups was examined in this study. We used…”
Get more information

SUN-374 B-CELL DEPLETION AND RESPONSE IN A RANDOMIZED, CONTROLLED TRIAL OF OBINUTUZUMAB FOR PROLIFERATIVE LUPUS NEPHRITIS by Rovin, B., Furie, R., Aroca, G., Garg, J.P., Alvarez, A., Fragoso-Loyo, H., Zuta Santillan, E., Brunetta, P., Schindler, T., Looney, C.M.D., Hassan, I., Cascino, M.D., Malvar, A.

Get full text

Outcomes of Non-Severe Relapses in ANCA-Associated Vasculitis Treated with Glucocorticoids by Miloslavsky, EM, Specks, U, Merkel, PA, Seo, P, Spiera, R, Langford, CA, Hoffman, GS, Kallenberg, CGM, St. Clair, EW, Tchao, NK, Ding, L, Ikle, D, Villareal, M, Lim, N, Brunetta, P, Fervenza, FC, Monach, PA, Stone, JH

Get full text

Rituximab for the Treatment of Relapses in ANCA-associated Vasculitis by Miloslavsky, EM, Specks, U, Merkel, PA, Seo, P, Spiera, R, Langford, CA, Hoffman, GS, Kallenberg, CGM, St. Clair, EW, Tchao, NK, Viviano, L, Ding, L, Ikle, D, Villarreal, M, Jepson, B, Brunetta, P, Allen, NB, Fervenza, FC, Geetha, D, Keogh, K, Kissin, EY, Monach, PA, Peikert, T, Stegeman, C, Ytterberg, SR, Stone, JH

Get full text

Effect of Rituximab (RTX) Treatment on the Immune System in Patients with Systemic Lupus Erythematosus (SLE) in the EXPLORER Trial by Tew, G, Rabbee, N, Monroe, J, Behrens, T, Brunetta, P, Keir, M

Get full text

PSY47 VALIDATION OF THE FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY (FACIT)—FATIGUE SCALE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) by Lai, JS, Beaumont, J, Cella, D, Brunetta, P, Ogale, S

Get full text

PSY49 VALIDATION OF THE SF-36 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) by Beaumont, J, Lai, JS, Cella, D, Brunetta, P, Ogale, S

Get full text

Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis by Miloslavsky, E., Specks, U., Merkel, P., Seo, P., Spiera, R., Langford, C., Hoffman, G., Kallenberg, C., St. Clair, W., Tchao, N., Ding, L., Ikle, D., Jepson, B., Brunetta, P., Stone, J.

Get full text

Retreatment with Rituximab in the RAVE Trial by Miloslavsky, E., Specks, U., Merkel, P., Seo, P., Spiera, R., Langford, C., Hoffman, G., Kallenberg, C., St. Clair, W., Tchao, N., Ding, L., Ikle, D., Jepson, B., Brunetta, P., Stone, J.

Get full text

Italian cinema and the hard road towards democracy, 1945 by Brunetta, Gian Piero

“…The films of Roberto Rosselini and other Italian directors do not glorify heroism. Instead, they expose the rediscovery of common moral principles and ideals…”
Get full text